BAC
Bank of America Corporation
BAC has a slight edge over RKT overall, supported by lower modeled downside and stronger modeled upside.
RKT
Rocket Companies, Inc.
RKT offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
RKT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| N/A | |
| N/A |
RKT's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like RKT.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over RKT in the historical PE scenario, which offers more potential upside but is not a forecast.
RKT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 0.7x | $0.36 | -97% |
| Fair | 0.9x | $0.47 | -97% |
| Forward | 23x | $13.71 | — |
| Current | 26x | $13.71 | — |
| Expensive | 57x | $30.08 | +119% |
Historical ranges are pointers, not guarantees.
RKT's PE is 26x, but its earnings don't support one, so it isn't a reliable read right now.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over RKT on the outlook, with more favorable revenue expectations.
RKT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RKT's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC's earnings per share have climbed steadily: $4.19 over the past year, up 14% from the year before, and higher year over year for eight quarters in a row.
RKT Earnings Per Share
RKT and BAC do not have enough comparable growth data to identify a winner.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC's revenue has grown year over year for 10 quarters in a row: $30B last quarter, up 6.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over RKT on profitability, with a higher operating margin.
RKT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3.3B | +105% |
| Q2 2026 | $2.8B | +105% |
| Q1 2026 | $2.9B | +184% |
| Q4 2025 | $2.7B | +52% |
| Q3 2025 | $1.6B | +148% |
| Q2 2025 | $1.4B | +4.6% |
| Q1 2025 | $1B | -25% |
| Q4 2024 | $1.8B | +155% |
RKT's revenue is recovering but still below its 2020 peak: $3.3B last quarter, up 105% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 29% | +41 points |
| Q2 2026 | 10% | +8.3 points |
| Q1 2026 | 14% | +35 points |
| Q4 2025 | 6.3% | -32 points |
| Q3 2025 | -11% | +65 points |
| Q2 2025 | 1.8% | -13 points |
| Q1 2025 | -22% | -43 points |
| Q4 2024 | 38% | +73 points |
RKT's operating margin was 29% last quarter, up 41 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
RKT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.9B | +$1.9B |
| Q2 2026 | -$1.2B | +$619.6M |
| Q1 2026 | $1.8B | +$2.6B |
| Q4 2025 | -$1.3B | -170% |
| Q3 2025 | -$71.8M | +$1.3B |
| Q2 2025 | -$1.9B | -$1.7B |
| Q1 2025 | -$811M | +$2.2B |
| Q4 2024 | $1.8B | +31% |
RKT has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over RKT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
RKT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +1.9M shares |
| 1 year | +42% | +842M shares |
| 3 years | +43% | +856M shares |
RKT has 2.8B diluted shares, up 42% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | $11.7M |
| Q3 2022 | $20.6M |
| Q2 2022 | $45.3M |
| Q1 2022 | $100.2M |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
RKT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.3x | Elevated |
| Q2 2026 | 6.4x | High |
| Q1 2026 | 9.5x | High |
| Q4 2025 | 287.9x | High |
| Q3 2025 | 29.1x | High |
| Q2 2025 | 136.0x | High |
| Q1 2025 | 39.5x | High |
| Q4 2024 | 12.1x | High |
RKT has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
RKT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.4 | Neutral |
| Stochastic | 72.6 | Neutral |
RKT's weekly RSI is 50 (neutral) and its Stochastic is 73 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over RKT on valuation relative to its sector.
RKT PE vs Financial Services Sector
| Metric | RKT | Sector median | Relative |
|---|---|---|---|
| PE | 26x | 13x | 99% above |
| PE % | 62 | 62 | Same percentile |
RKT is trading at 26x earnings, a 99% premium to the Financial Services sector's median of 13x, though its earnings don't support one.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
RKT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $12.4 | 10% above |
| 20 week MA | $13.3 | 3.2% above |
| 50 week MA | $15.3 | 11% below |
| 100 week MA | $15.1 | 9.3% below |
| 200 week MA | $13.6 | 0.9% above |
RKT has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has the edge over RKT on returns for 2026, with the stronger performance.
RKT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $24.9 | $20.8 | -16% |
| 2021 | $20.8 | $15.3 | -27% |
| 2022 | $15.3 | $7.29 | -52% |
| 2023 | $7.29 | $14.5 | +99% |
| 2024 | $14.5 | $11.1 | -23% |
| 2025 | $11.1 | $19.4 | +75% |
| 2026 YTD | $19.4 | $13.7 | -29% |
RKT has finished lower in four of the last six years. It's down 29% so far in 2026.